Jyi Cheng Ng, MD
@JyiChengNg
Followers
551
Following
1K
Media
31
Statuses
320
Halsted Intern @hopkinssurgery | CRS Research Fellow @MayoClinicSurg | @IASSS_1 Office | ✝️🇲🇾
Joined December 2021
Can’t do a #GenSurgMatch2025 post without @DrDavidLarson @KellieLMathisMD @YWLum!. I wouldn’t be where I am today without ✝️ and I’m especially blessed with mentors who’re invested in my growth. Grateful for EVERYONE I’ve crossed paths with and the opportunities along the way!!!
8
6
151
0
4
0
RT @chrisvarghese98: 🚨Excited to share @TASMANCollab's latest paper, just pub'd in @npjDigitalMed. ⚡️See our personalised approach to predi….
0
2
0
RT @WiscSurgery: Dr. John Stulak joins us as the Chair of the Division of Cardiothoracic Surgery. In this position, he will lead and direct….
0
4
0
RT @MayoClinicSurg: An #AI tool developed by researchers at #MayoClinicMN can detect surgical site infections in photos submitted by patien….
0
1
0
RT @tarik_sammour: Wow. If it makes this much difference in locally advanced colon cancer, imagine the potential survival advantage in nod….
0
7
0
Neoadjuvant chemotherapy significantly improves 5-year OS, DFS, and surgical margin outcomes in locally advanced colon cancer. @RichardSassun @AnnaclaraS65 @DrDavidLarson.
Featured: Oncological Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery in Locally Advanced #ColonCancer : A Systematic Review, Meta-Analysis, and Sequential Analysis. @RichardSassun. . @csabagajdos1.@SyedAAhmad5
0
4
18
RT @EuroSurg: How can YOU get involved? 🫵🧵. Whether you're an expert researcher or looking to get involved in it for the first time, a colo….
0
4
0
RT @MayoClinicSurg: A study led by @MayoClinic clinicians shows that neoadjuvant chemotherapy (NAC) improves 5-year survival in locally adv….
0
8
0
RT @Ibrahim_Gomaa95: 📣📣Excited to share our publication in @AnnSurgOncol on the impact of RAS/BRAF mutations on pCR in rectal cancer in the….
0
9
0
RT @JHHVascular: Today is the last day of fellowship for our senior fellow @AlexisLauria1 ! Congratulations on all that you have accomplish….
0
6
0
RT @chrisvarghese98: Excited to see our meta-analysis of ICC deficits in chronic gastroduodenal disorders, out now in @AmJGastro! 🔬. We sho….
0
2
0
Huge thanks to the CRS Division and @DrDavidLarson for the opportunity to work on this project!.
A study led by @MayoClinic surgeons shows total neoadjuvant therapy followed by surgery to treat advanced #RectalCancer leads to excellent outcomes, including low recurrence and a high percentage of cancer-specific survival. Read the study to learn more:
1
2
25
RT @elliotthaut: ATLS Trauma training for our incoming @hopkinssurgery residents is always a fun learning day. I don’t think they realize….
0
5
0
RT @elliotthaut: State of the Department at @hopkinssurgery by our chair and genuinely great human being- @AndrewMCameron. Thank your for y….
0
13
0
Had a such a great time in ISW2024 last year meeting like-minded individuals from around the 🌎. Don’t miss the opportunity to join #ISW2026 in Mexico City as a FSP delegate! 👇.
Applications for the FSP are NOW OPEN!🩺. Join us for the 51st International Surgical Week in Mexico City from 19-23 April 2026🇲🇽. *Applications close:* 30 June 2025 . Queries: board@iasss.org . *Link to form:
0
0
1
🔥 Hot off the press in @ejsotweets!. Real-world surgical & oncological outcomes of rectal cancer patients treated with TNT followed by TME at @MayoClinicSurg. 🔗: Huge thanks to 🧢 @DrDavidLarson and coauthors @RichardSassun @AnnaclaraS65 @tommyv1992
0
5
14
RT @RichardSassun: Great work @JyiChengNg!.Showing what the results really are in non-RCT settings.
0
2
0
RT @RichardSassun: Great news!🔥.In our new RCTs Metanalysis, OS and DFS were improved with Neoadjuvant Chemotherapy compared to Adjuvant Ch….
link.springer.com
Annals of Surgical Oncology - Neoadjuvant chemotherapy (NAC) has emerged as a potential alternative to upfront surgery (US) followed by adjuvant chemotherapy in locally advanced colon cancer...
0
6
0
RT @RichardSassun: Diverticulitis' incidence is rising, but surgery is not always recommended, especially for uncomplicated cases. We delv….
0
4
0